Component: (Network and Table) | |
---|---|
Network | 00500 - Statement - Consolidated Statements of Cash Flows (http://www.supernus.com/role/StatementConsolidatedStatementsOfCashFlows) |
Table | (Implied) |
Reporting Entity [Axis] | 0001356576 (http://www.sec.gov/CIK) |
Consolidated Statements of Cash Flows | Period [Axis] | ||
---|---|---|---|
2016-01-01 - 2016-12-31 | 2015-01-01 - 2015-12-31 | 2014-01-01 - 2014-12-31 | |
Consolidated Statements of Cash Flows | |||
Cash flows from operating activities | |||
Net income (loss) | 91,221,000 | 13,944,000 | (10,925,000) |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||
Loss on extinguishment of debt | 671,000 | 2,338,000 | 2,592,000 |
Change in fair value of derivative liability | ( | ( | ( |
Unrealized loss on marketable securities | ( | ||
Depreciation and amortization | |||
Amortization of deferred financing costs and debt discount | |||
Noncash interest expense on nonrecourse liability related to sale of future royalties | 4,548,000 | 3,541,000 | 658,000 |
Non-cash royalty revenue | ( | ( | ( |
Share-based compensation expense | |||
Deferred income tax benefit | ( | ||
Changes in operating assets and liabilities: | |||
Accounts receivable | ( | ( | ( |
Inventories | ( | ( | |
Prepaid expenses and other assets | ( | ( | |
Accounts payable | ( | ||
Accrued sales deductions | |||
Accrued expenses | |||
Deferred product revenue, net | ( | ||
Deferred licensing revenue | ( | ||
Other non-current liabilities | ( | ||
Net cash provided by (used in) operating activities | ( | ||
Cash flows from investing activities | |||
Purchases of marketable securities | ( | ( | ( |
Sales and maturities of marketable securities | |||
Purchases of property and equipment | ( | ( | ( |
Deferred legal fees | ( | ( | ( |
Net cash used in investing activities | ( | ( | ( |
Cash flows from financing activities | |||
Proceeds from issuance of common stock | |||
Cash settlement of debt to equity conversion | ( | ||
Proceeds from sale of future royalties | |||
Net cash provided by financing activities | |||
Net change in cash and cash equivalents | ( | ||
Cash and cash equivalents at beginning of year | 33,498,000 | ||
Cash and cash equivalents at end of year | 66,398,000 | 33,498,000 | 36,396,000 |
Supplemental cash flow information: | |||
Cash paid for interest | |||
Noncash financial activity: | |||
Conversion of convertible notes and interest make-whole | |||
Exercise of warrants | |||
Deferred legal fees included in accounts payable and accrued expenses |